Cancer glossary
The XELOX (CAPOX) regimen: capecitabine and oxaliplatin — how treatment goes
XELOX, also called CAPOX, is a chemotherapy regimen of oxaliplatin and capecitabine tablets. Who gets it, how the 21-day cycle works and which side effects to watch.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
XELOX (CAPOX) is a chemotherapy regimen: oxaliplatin is given by drip, and capecitabine tablets are taken at home for two weeks. No pump or long infusion is needed.
How it appears in your prescription
- ‘XELOX: oxaliplatin 130 mg/m² on day 1 + capecitabine 1000 mg/m² twice a day on days 1–14, every 21 days’.
- ‘CAPOX × 4 cycles (3 months) adjuvant’ or ‘× 8 cycles (6 months)’.
- ‘CAPOX + bevacizumab’ — in metastatic cancer.
What it means
According to the US National Cancer Institute, CAPOX is used in colon cancer after surgery, in metastatic colorectal cancer and in stomach cancer. Its effectiveness is comparable to FOLFOX; the choice depends on whether a person finds tablets or a pump more convenient, and on tolerance.
Side effects
From oxaliplatin — cold sensitivity and cumulative neuropathy. From capecitabine — hand-foot syndrome and diarrhea. Also nausea, fatigue and low platelets.
Stop the tablets and contact your doctor with diarrhea more than 4 times a day, blisters on the palms or soles, or a temperature of 38 °C (100.4 °F) or higher.
Questions to ask your doctor
- 3 months or 6 — and why?
- What should I do if I miss a dose?
- Was I tested for DPD deficiency?
Sources
- CAPOX — National Cancer Institute
- Capecitabine — National Cancer Institute
- Oxaliplatin — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
